These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17374963)

  • 1. Frequency of mutated allele CYP2D6*4 in the Turkish population.
    Koseler A; Ilcol YO; Ulus IH
    Pharmacology; 2007; 79(4):203-6. PubMed ID: 17374963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequencies of mutated alleles of CYP2D6 gene in a Turkish population.
    Serin A; Canan H; Alper B; Gulmen M
    Forensic Sci Int; 2012 Oct; 222(1-3):332-4. PubMed ID: 22910059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2D6 and CYP1A1 mutations in the Turkish population.
    Aydin M; Hatirnaz O; Erensoy N; Ozbek U
    Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of CYP2D6 in Chinese mainland.
    Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M
    Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
    Buzková H; Pechandová K; Slanar O; Perlík F
    Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of CYP2D6 in the Japanese population.
    Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
    Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 CYP2D6.
    Wolf CR; Smith G
    IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls.
    Erden G; Acar FS; Inal EE; Soydas AO; Ozoran K; Bodur H; Yildirimkaya MM
    Rheumatol Int; 2009 Oct; 29(12):1431-4. PubMed ID: 19242697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.
    Bathum L; Johansson I; Ingelman-Sundberg M; Hørder M; Brøsen K
    Pharmacogenetics; 1998 Apr; 8(2):119-23. PubMed ID: 10022749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
    Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of CYP2D6 poor metabolizers among schizophrenia patients.
    Llerena A; Dorado P; Peñas-Lledó EM; Cáceres MC; De la Rubia A
    Pharmacogenomics J; 2007 Dec; 7(6):408-10. PubMed ID: 17325735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
    Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
    Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
    J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.
    Kato D; Kawanishi C; Kishida I; Furuno T; Matsumura T; Hasegawa H; Suzuki K; Hirayasu Y
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):504-7. PubMed ID: 16048458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
    Halling J; Weihe P; Brosen K
    Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction.
    Endrizzi K; Fischer J; Klein K; Schwab M; Nüssler A; Neuhaus P; Eichelbaum M; Zanger UM
    Anal Biochem; 2002 Jan; 300(2):121-31. PubMed ID: 11779102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacogenetics in the treatment of schizophrenia].
    Saito M; Yasui-Furukori N; Kaneko S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype.
    Ishiguro A; Kubota T; Sasaki H; Iga T
    Clin Chim Acta; 2004 Sep; 347(1-2):217-21. PubMed ID: 15313161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study.
    Teh LK; Zilfalil BA; Marina I; Rosemi BS; Ismail R
    J Clin Pharm Ther; 2004 Dec; 29(6):559-64. PubMed ID: 15584944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.